Melissa Angela Pugliano-Mauro MD
Dermatologic Surgery
Associate Professor, Dermatology, University of Pittsburgh School of Medicine
Join to view full profile
2585 Freeport RdSuite 240Pittsburgh, PA 15238
Phone+1 412-784-7350
Fax+1 412-784-7351
Dr. Pugliano-Mauro is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Vermont Medical CenterFellowship, Micrographic Surgery and Dermatologic Oncology, 2008 - 2009- University of Vermont Medical CenterResidency, Dermatology, 2005 - 2008
Allegheny Health Network Medical Education Consortium (WPH)Internship, Transitional Year, 2004 - 2005
Drexel University College of MedicineClass of 2004
Certifications & Licensure
PA State Medical License 2004 - 2026
VT State Medical License 2005 - 2010
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification dbMotion, dbMotion Inc., 2012-2017
Clinical Trials
- Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC Start of enrollment: 2018 Aug 03
Publications & Presentations
PubMed
- Retrospective cohort study on efficacy of extended treatment intervals of intralesional 5-fluorouracil in low-risk squamous cell carcinoma.Jonathan C Hwang, Kevin T Savage, Reethi S Padmanabhan, Melissa Pugliano-Mauro
Journal of the American Academy of Dermatology. 2026-11-01 - Feasibility of a culturally tailored traction alopecia prevention curriculum in a diverse urban middle school: a pilot study.Aliyyat Afolabi, Edra K Ha, Oreoluwa Fawole, Beth Hoffman, Melissa Pugliano-Mauro
International Journal of Women's Dermatology. 2026-10-01 - Immune Checkpoint Inhibitors in Advanced Sebaceous Carcinoma: A Systematic Review, Biomarker Analysis, and Clinical Recommendations.Nana-Hawwa Abdul-Rahman, Lucie Joerg, Connor Gill, Luis J Borda, Katherine G Thompson
Journal of Cutaneous Medicine and Surgery. 2026-08-21
Press Mentions
Study Adds Evidence That Nicotinamide Prevents Skin CancersSeptember 22nd, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: